{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:27:46Z","timestamp":1778678866630,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jfo.2023.01.030","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T07:30:26Z","timestamp":1683099026000},"page":"929-940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"46","author":[{"given":"H.","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2023.01.030_bib0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.47102\/annals-acadmedsg.V33N1p27","article-title":"Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000","volume":"33","author":"Lin","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jfo.2023.01.030_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1475-1313.2011.00886.x","article-title":"Prevalence of myopia among Hong Kong Chinese schoolchildren: changes over two decades. Ophthalmic & physiological optics","volume":"32","author":"Lam","year":"2012","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.jfo.2023.01.030_bib0230","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000207","article-title":"Myopia control: a review","volume":"42","author":"Walline","year":"2016","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2023.01.030_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2011.03.012","article-title":"Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis","volume":"118","author":"Marcus","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0245","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0002-9394(02)01883-4","article-title":"Pathologic myopia: where are we now?","volume":"134","author":"Tano","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0250","first-page":"Cd004916","article-title":"Interventions to slow progression of myopia in children","author":"Walline","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfo.2023.01.030_bib0255","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0260","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0265","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12886-020-01746-w","article-title":"Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0270","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","article-title":"Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis","volume":"129","author":"Ha","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0275","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jfo.2023.01.030_bib0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1999.15.85","article-title":"Effects of different concentrations of atropine on controlling myopia in myopic children","volume":"15","author":"Shih","year":"1999","journal-title":"J Ocul PharmacolTher"},{"key":"10.1016\/j.jfo.2023.01.030_bib0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1600-0420.2001.790304.x","article-title":"An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression","volume":"79","author":"Shih","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2023.01.030_bib0290","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/sim.2211","article-title":"Inference of nested variance components in a longitudinal myopia intervention trial","volume":"24","author":"Hsiao","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.jfo.2023.01.030_bib0295","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ctim.2008.04.007","article-title":"A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial","volume":"16","author":"Liang","year":"2008","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.jfo.2023.01.030_bib0305","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1167\/iovs.14-14716","article-title":"Analysis of changes in refraction and biometry of atropine- and placebo-treated eyes","volume":"56","author":"Kumaran","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2023.01.030_bib0310","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaapos.2015.04.006","article-title":"Therapeutic effect of atropine 1% in children with low myopia","volume":"19","author":"Yi","year":"2015","journal-title":"J AAPOS"},{"key":"10.1016\/j.jfo.2023.01.030_bib0315","doi-asserted-by":"crossref","first-page":"e7371","DOI":"10.1097\/MD.0000000000007371","article-title":"Atropine 0.5% eyedrops for the treatment of children with low myopia: a randomized controlled trial","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jfo.2023.01.030_bib0320","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0325","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0330","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10792-020-01658-0","article-title":"Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children","volume":"41","author":"Zhao","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0335","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7150\/ijms.39365","article-title":"Efficacy and safety of 1% atropine on retardation of moderate myopia progression in Chinese school children","volume":"17","author":"Zhu","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jfo.2023.01.030_bib0340","first-page":"1","article-title":"Atropine 0.01% for the control of myopia in Chinese children: effect on accommodation functions and pupil size","volume":"2020","author":"Wang","year":"2020","journal-title":"Journal of Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3329\/bsmmuj.v13i4.50499","article-title":"Topical atropine in retarding myopia progression and axial length growth in children with myopia","volume":"13","author":"Alam","year":"2020","journal-title":"Bangabandhu Sheikh Mujib Medical University Journal"},{"key":"10.1016\/j.jfo.2023.01.030_bib0350","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in india: multicentric randomized trial","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0355","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/09286586.2021.1875010","article-title":"Comparison of the clinical efficacies of 0.01% atropine and orthokeratology in controlling the progression of myopia in children","volume":"28","author":"Zhao","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0360","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0365","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s10792-021-01855-5","article-title":"Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination","volume":"41","author":"Hao","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0370","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/ICL.0b013e31824ccbc3","article-title":"The prevalence and impact of high myopia","volume":"38","author":"Jones","year":"2012","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2023.01.030_bib0375","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12886-017-0483-6","article-title":"The increasing prevalence of myopia in junior high school students in the Haidian District of Beijing, China: a 10-year population-based survey","volume":"17","author":"Li","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0380","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.ophtha.2021.04.001","article-title":"COVID-19 quarantine reveals that behavioral changes have an effect on myopia progression","volume":"128","author":"Xu","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0385","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1136\/bjophthalmol-2021-319307","article-title":"Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study","volume":"106","author":"Zhang","year":"2022","journal-title":"British Journal of Ophthalmology"},{"key":"10.1016\/j.jfo.2023.01.030_bib0390","doi-asserted-by":"crossref","first-page":"662984","DOI":"10.3389\/fped.2021.662984","article-title":"Adolescent vision health during the outbreak of COVID-19: association between digital screen use and myopia progression","volume":"9","author":"Liu","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jfo.2023.01.030_bib0395","first-page":"Cd004916","article-title":"Interventions to slow progression of myopia in children","volume":"1","author":"Walline","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfo.2023.01.030_bib0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12886-019-1112-3","article-title":"Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses","volume":"19","author":"Prousali","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jfo.2023.01.030_bib0405","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/ICL.0000000000000499","article-title":"A review of current concepts of the etiology and treatment of myopia","volume":"44","author":"Cooper","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2023.01.030_bib0410","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ICL.0000000000000189","article-title":"Use of atropine for prevention of childhood myopia progression in clinical practice","volume":"42","author":"Shih","year":"2016","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2023.01.030_bib0415","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jop.2011.0017","article-title":"Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials","volume":"27","author":"Song","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2023.01.030_bib0420","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/OPX.0000000000000178","article-title":"Atropine slows myopia progression more in Asian than white children by meta-analysis","volume":"91","author":"Li","year":"2014","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jfo.2023.01.030_bib0425","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/APO.0000000000000414","article-title":"A meta-analysis assessing change in pupillary diameter, accommodative amplitude, and efficacy of atropine for myopia control","volume":"10","author":"Tran","year":"2021","journal-title":"Asia Pac J Ophthalmol (Philadelphia, Pa)"},{"key":"10.1016\/j.jfo.2023.01.030_bib0430","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jfma.2022.05.005","article-title":"Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis","volume":"121","author":"Tsai","year":"2022","journal-title":"J Formos Med Assoc"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223002255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223002255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:21:10Z","timestamp":1759260070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551223002255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0181551223002255"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2023.01.030","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2023.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}